These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11284062)

  • 1. [Current pathogenetic aspects of Sézary syndrome and mycosis fungoides].
    Dummer R; Willers J; Döbbeling U; Burg G
    Hautarzt; 2001 Mar; 52(3):189-92. PubMed ID: 11284062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
    Wong HK; Mishra A; Hake T; Porcu P
    Br J Haematol; 2011 Oct; 155(2):150-66. PubMed ID: 21883142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
    Bachelez H
    Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
    [No Abstract]   [Full Text] [Related]  

  • 4. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
    Furue M; Kadono T
    J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T-cell lymphomas. A review of the recent literature.
    Zackheim HS
    Arch Dermatol; 1981 May; 117(5):295-304. PubMed ID: 6971626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of mycosis fungoides.
    Norris DA
    Clin Exp Dermatol; 1981 Jan; 6(1):77-87. PubMed ID: 7023759
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycosis Fungoides and Sézary Syndrome: An Update.
    Larocca C; Kupper T
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):103-120. PubMed ID: 30497668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology and treatment of cutaneous T-cell lymphoma.
    Goel RR; Rook AH
    Expert Rev Clin Immunol; 2024 Aug; 20(8):985-996. PubMed ID: 38450476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.
    Kuzel TM; Roenigk HH; Rosen ST
    J Clin Oncol; 1991 Jul; 9(7):1298-313. PubMed ID: 2045869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
    Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of the Workshop on Cutaneous T-Cell Lymphomas (Mycosis Fungoides and Sézary Syndrome). Introduction.
    Lamberg SI; Bunn PA
    Cancer Treat Rep; 1979 Apr; 63(4):561-4. PubMed ID: 376139
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycosis fungoides and Sézary syndrome.
    Hwang ST; Janik JE; Jaffe ES; Wilson WH
    Lancet; 2008 Mar; 371(9616):945-57. PubMed ID: 18342689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T-cell lymphoma: a review.
    Winkler CF; Bunn PA
    Crit Rev Oncol Hematol; 1983; 1(1):49-92. PubMed ID: 6083835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new molecular paradigm in mycosis fungoides and Sézary syndrome.
    Elenitoba-Johnson KS; Wilcox R
    Semin Diagn Pathol; 2017 Jan; 34(1):15-21. PubMed ID: 28024703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides and the Sézary syndrome.
    Gisselbrecht C; Dubertret L
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.